In vitro characterization of immune-related properties of human fetal bone cells for potential tissue engineering applications
Publisher DOI
PubMed ID
19196143
Abstract
We describe herein some immunological properties of human fetal bone cells recently tested for bone tissue-engineering applications. Adult mesenchymal stem cells (MSCs) and osteoblasts were included in the study for comparison. Surface markers involved in bone metabolism and immune recognition were analyzed using flow cytometry before and after differentiation or treatment with cytokines. Immunomodulatory properties were studied on activated peripheral blood mononuclear cells (PBMCs). The immuno-profile of fetal bone cells was further investigated at the gene expression level. Fetal bone cells and adult MSCs were positive for Stro-1, alkaline phosphatase, CD10, CD44, CD54, and beta2-microglobulin, but human leukocyte antigen (HLA)-I and CD80 were less present than on adult osteoblasts. All cells were negative for HLA-II. Treatment with recombinant human interferon gamma increased the presence of HLA-I in adult cells much more than in fetal cells. In the presence of activated PBMCs, fetal cells had antiproliferative effects, although with patterns not always comparable with those of adult MSCs and osteoblasts. Because of the immunological profile, and with their more-differentiated phenotype than of stem cells, fetal bone cells present an interesting potential for allogeneic cell source in tissue-engineering applications.
Date Issued
2009
Publication Type
Article
Language(s)
en
Author(s)
Montjovent, Marc-Oliver | |
Bocelli-Tyndall, C | |
Scaletta, C | |
Scherberich, A | |
Mark, S | |
Martin, I | |
Applegate, LA | |
Pioletti, DP |
Additional Credits
Journal
Tissue engineering. Part A
Publisher
Mary Ann Liebert
ISSN
1937-3341
ISBN
19196143
Access(Rights)
Unknown